Orthofix Medical Inc. (NASDAQ:OFIX) Insider Sells $71,164.20 in Stock

Orthofix Medical Inc. (NASDAQ:OFIX) insider Lucas Vitale sold 4,287 shares of the company’s stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $16.60, for a total transaction of $71,164.20. Following the transaction, the insider now owns 135,317 shares of the company’s stock, valued at $2,246,262.20. This represents a 3.07 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Orthofix Medical Trading Down 1.6 %

Orthofix Medical stock opened at $16.63 on Friday. The firm has a 50 day simple moving average of $17.77 and a 200-day simple moving average of $17.36. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.39 and a quick ratio of 1.11. The stock has a market capitalization of $648.94 million, a PE ratio of -5.31 and a beta of 1.06. Orthofix Medical Inc. has a 12-month low of $12.08 and a 12-month high of $20.73.

Wall Street Analysts Forecast Growth

Several research analysts have commented on OFIX shares. StockNews.com upgraded shares of Orthofix Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, February 25th. Roth Mkm reissued a “buy” rating and issued a $22.00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. Finally, Canaccord Genuity Group reissued a “buy” rating and issued a $24.00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $23.33.

Hedge Funds Weigh In On Orthofix Medical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OFIX. Franklin Resources Inc. boosted its stake in Orthofix Medical by 37.4% during the third quarter. Franklin Resources Inc. now owns 20,960 shares of the medical device company’s stock valued at $337,000 after buying an additional 5,702 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Orthofix Medical by 14.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 324,807 shares of the medical device company’s stock valued at $5,073,000 after purchasing an additional 39,901 shares in the last quarter. Barclays PLC boosted its position in shares of Orthofix Medical by 38.8% during the 3rd quarter. Barclays PLC now owns 122,472 shares of the medical device company’s stock valued at $1,912,000 after purchasing an additional 34,210 shares in the last quarter. HighTower Advisors LLC boosted its holdings in Orthofix Medical by 114.9% during the third quarter. HighTower Advisors LLC now owns 89,183 shares of the medical device company’s stock worth $1,393,000 after buying an additional 47,680 shares in the last quarter. Finally, Kirr Marbach & Co. LLC IN bought a new stake in Orthofix Medical during the fourth quarter worth approximately $532,000. 89.76% of the stock is owned by institutional investors.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.